Aditxt, Inc. (NASDAQ:ADTX – Free Report)’s stock is going to reverse split before the market opens on Wednesday, October 2nd. The 1-40 reverse split was announced on Friday, September 27th. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, October 1st.
Aditxt Stock Performance
NASDAQ:ADTX opened at $0.16 on Friday. The stock’s 50 day moving average price is $0.81 and its 200 day moving average price is $1.76. Aditxt has a 52 week low of $0.16 and a 52 week high of $24.00.
Aditxt (NASDAQ:ADTX – Get Free Report) last posted its earnings results on Monday, August 19th. The company reported ($4.19) EPS for the quarter. Aditxt had a negative return on equity of 615.43% and a negative net margin of 5,016.31%. The business had revenue of $0.04 million during the quarter.
Aditxt Company Profile
Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.
See Also
- Five stocks we like better than Aditxt
- What is the FTSE 100 index?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- 3 Monster Growth Stocks to Buy Now
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
